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Abstract
Background: Shigellosis is one of the major causes of morbidity in children with diarrhea in Iran.
The present study was undertaken to characterize apparently sporadic Shigella boydii strains
isolated from pediatric patients in Iran.
Findings: Ten S. boydii strains isolated from pediatric cases of gastroenteritis and acute diarrhea
in Tehran between December 2002 and November 2003 were submitted to serotyping,
antimicrobial susceptibility testing, plasmid profile analysis, ribotyping and pulsed field gel
electrophoresis (PFGE). Seven isolates were attributed to serotype 2, whereas the remaining three
belonged to serotypes 14, 18, 19, respectively. Six drug resistance phenotypes (R1 to R6) were
defined with R4 – streptomycin (STR), ampicillin (AMP), sulfamethoxazole-trimethoprim (SXT) –
being the most prevalent. Plasmid analysis resulted in seven different plasmid profiles with one to
five DNA bands. All strains, but one, shared the same ribotype, but PFGE differentiated them in
four groups.
Conclusion: Based upon ribotyping and PFGE results, endemic circulation of S. boydii in Tehran,
Iran, could be attributed to a few clones. Resistance pattern and plasmid profile analysis proved to
be very effective in discriminating apparently unrelated strains of S. boydii.
Findings
Shigellosis is one of the major causes of morbidity and
mortality in children with diarrhea in developing coun-
tries. Worldwide, the disease causes around 1,100,000
deaths per year, and two-thirds of the patients are children
under 5 years of age. Shigellosis is caused by four sero-
groups of Shigella including serogroup A (S. dysenteriae),
serogroup B (S. flexneri), serogroup C (S. boydii), and sero-
group D (S. sonnei). Among Shigella serogroups, S. flexneri
and S. sonnei are most prevalent in the developing and
industrialized countries, respectively. S. dysenteriae is
detected mostly in South Asia and sub-Saharian Africa [1].
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S. boydii has been less frequently reported worldwide
compared to other Shigella serogroups [2,3]. It is relatively
rare in developed countries and is typically associated
with individuals who have travelled to endemic areas. Iso-
lation rate of this species is less than 1–2% of the total
Shigella isolates, except in the Indian subcontinent [4].
Shigellosis is one of the major causes of morbidity in chil-
dren with diarrhea in Iran [5-9], but reports about preva-
lence of Shigella  serogroups and their phenotypic and
genetic epidemiological features are limited. Furthermore,
specific studies to investigate the relatedness between the
S. boydii strains isolated from clinical cases in Iran have
never been undertaken.
Several typing methods such as serotyping, drug resistance
pattern, plasmid analysis, ribotyping, and pulsed field gel
electrophoresis (PFGE) have been frequently used for sub-
typing of Shigella in epidemiological investigations [3,10-
14].
The present study was undertaken to characterize S. boydii
strains isolated from pediatric cases of gastroenteritis and
acute diarrhea in Tehran, Iran, between December 2002
and November 2003 by serotyping, antimicrobial suscep-
tibility testing, plasmid profile analysis, ribotyping and
PFGE. To the best of our knowledge this is the first study
of its kind to be carried out in Iran.
Methods
Bacterial strains
Fecal specimens and rectal swabs were inoculated into
Cary-Blair transport medium and processed within 2–4 h.
Specimens were cultured on Shigella-Salmonella (SS), Hek-
toen-Enteric (HE), Xylose Lysine Deoxycholate (XLD) and
MacConkey (MC) agars (Difco, Detroit, MI, USA) and
incubated at 37°C for 24 h. Suspected colonies were
picked from the culture plates and subjected to further
analysis by biochemical tests for the identification of pos-
sible  Shigella  colonies.  Shigella  spp. were preliminarily
identified by Gram stain, colony morphology, lactose fer-
mentation, motility, as well as by API20E [15].
For serotyping, strains of Shigella  were subcultured on
trypticase soy agar (Difco, Detroit, MI, USA) and tested for
agglutination on glass slides. Strains were serogrouped by
using commercially-available polyclonal antisera from
MAST Group LTD (Mast House, Derby Road, Bootle, Mer-
seyside, L201EA). The serotypes of S. boydii were deter-
mined with commercially available monovalent antisera
(Staten Serum Institut, Copenhagen, Denmark).
Antimicrobial susceptibility testing
Antimicrobial susceptibility test was performed by the
disk diffusion method according to the guidelines of the
Clinical and Laboratory Standards Institute (formerly
National Committee for Clinical Laboratory Standards
[NCCLS], 2000) [16]. The following antimicrobial agents
were tested; ampicillin, AMP (10 μg); amoxicillin-clavu-
lanic acid, AMX (30 μg); cephalothin, CF (30 μg); cefix-
ime, CFM (5 μg); ceftazidime, CAZ (30 μg); ceftizoxime,
CT (30 μg); ceftriaxone, CRO (30 μg); amikacin, AN (30
μg); gentamicin, GM (10 μg); kanamycin, K (30 μg); strep-
tomycin, STR (10 μg); chloramphenicol, C (30 μg); sul-
famethoxazole-trimethoprim, SXT (23.75/1.25/μg);
tetracycline, TET (30 μg); ciprofloxacin, CP (5 μg); nalid-
ixic acid, NA (30 μg). Escherichia coli ATCC 25922 was
used as a quality control strain.
Plasmid profiling
The High Pure plasmid isolation kit (Roche, Mannheim,
Germany) was used to isolate the bacterial plasmids in
accordance with the manufacturer's recommendations.
This extraction procedure is suitable for detection of small
plasmids (less than 20 kbp molecular size) only. How-
ever, since large virulence plasmids carried by all four
Shigella serogroups are associated to virulence properties
and do not contribute to the discriminative power
[11,17,18], the method was considered to be reliable for
subtyping purposes.
Plasmid DNA was then separated on a 0.8% agarose gel in
Tris-borate-EDTA (TBE) buffer, pH 8.2, by horizontal elec-
trophoresis. The strains were grouped depending on their
banding pattern. Lambda DNA cleaved by EcoR1 and Hin-
dIII (Promega, Madison, WI, US) was used as electro-
phoresis marker.
Ribotyping
Ribotyping was performed according to previous reports
[19]. Bacterial DNA was digested with PvuII restriction
enzyme under conditions recommended by the manufac-
turer (Roche Diagnostics, Mannheim, Germany).
Digested DNA fragments were resolved on a 0.8% agarose
gel in TBE buffer and then transferred onto nylon mem-
brane by the alkali-blotting procedure on a vacuum blot-
ter. Hybridization was then performed with a
digoxigenin-11-dUTP (DIG) labeled oligonucleotide
probe mixture [20]. The membranes were then visualized
by addition of alkaline phosphate-conjugated anti-digox-
igenin antibody (Roche Diagnostic GmbH, Mannheim,
Germany) and nitroblue tetrazolium and 5-bromo-4-
chloro-3-indolyl phosphate as the substrate.
PFGE analysis
The S. boydii isolates were analyzed by PFGE after DNA
digestion with the restriction endonuclease XbaI
(Promega, Madison, WI, USA) using the PulseNet proto-
col [21]. DNA of Salmonella serotype Braenderup strain
H9812 was digested with XbaI and used as molecularBMC Research Notes 2008, 1:74 http://www.biomedcentral.com/1756-0500/1/2
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weight standard. Strain H9812 was kindly provided by the
National Reference Centre for Enteric Pathogens at the
Istituto Superiore di Sanità, Rome, Italy. The electro-
phoretic profiles were visually compared and interpreted
according to the criteria of Tenover et al. [22].
Results
During the one-year period from December 2002 and
November 2003, a total of 302 Shigella strains had been
isolated from enteritis cases in children at the Children
Medial Center and Mofid Children Hospital and three
additional large hospitals including Baqiyatallah, Millad
and Firozabadi in Tehran.
Ten isolates of S. boydii were available for the study. No
epidemiological relationship had been identified within
the strains by conventional investigation.
Seven strains belonged to serotype 2, whereas serotypes
14, 18, and 19 were each represented by one strain.
All isolates were resistant to sulfamethoxazole-trimetho-
prim and all, but one, to streptomycin. Additional resist-
ances to nalidixic acid or ampicillin were exhibited by
four isolates. The majority of the isolates were susceptible
to amoxicillin-clavulanic acid, chloramphenicol and tet-
racycline. All isolates were fully susceptible to kanamycin,
gentamicin, cephalothin, ceftriaxone, ceftizoxime, ceftazi-
dime, cefotaxime and ciprofloxacin. Table 1 summarizes
the antimicrobial resistance patterns.
Plasmid analysis of S. boydii resulted in seven different
plasmid profiles (P1 to P7) with one to five DNA bands
with a molecular weight lower than approximately 20 kb
(Fig. 1). The most prevalent plasmid profile was P6
(40%). Other plasmid profiles were unique (Table 1).
Drug resistance patterns combined with plasmid profiles
stratified the ten S. boydii isolates into nine groups.
Ribotyping produced 14 fragments when DNA from all S.
boydii isolates was digested with PvuII. Two ribotype pat-
terns were observed, of which ribotype I include nine iso-
lates and ribotype II one only isolate (Fig. 2).
Four pulsotypes, named A to D, were identified by XbaI-
PFGE among the isolates under study (Fig. 3). Type A
included seven isolates, whereas types B, C and D one iso-
late each, respectively.
The results of the different subtyping methods are illus-
trated by the Table 1. Combining results of the phenotypic
and genetic subtyping methods, nine different complete
patterns were identified.
Discussion
Of 302 Shigella isolates recovered from Iranian pediatric
cases in the period December 2002 to November 2003, 10
(3.3%) strains were identified as S. boydii and analyzed in
this study by different phenotypic and molecular subtyp-
ing methods. The prevalence rate of S. boydii is compara-
ble with a recent study in Iran in which 3.1% of Shigella
strains belonged to this serogroup [9].
Antimicrobial drug resistance pattern analysis has been
widely applied in epidemiologic studies of Shigella
through the years [23]. Using this method, six resistant
phenotypes were recognized with resistance to streptomy-
cin, ampicillin and sulfamethoxazole-trimethoprim being
the most frequent pattern. Our results suggest that this
method may represent an undemanding, but highly dis-
criminative approach for differentiation of S. boydii. More-
over, it is the least expensive and most widely available
subtyping tool and could be considered as a preliminary
screening approach in assessing strain relatedness. Never-
theless, significance of drug resistance profiles in long-
term epidemiologic studies is limited by two concurrent
factors: the strong selective pressure caused by antibacte-
rial drug abuse/misuse in hospital and, increasingly, in
Table 1: Characteristics of the S. boydii isolates included in the study
Strain No. Serotype Resistance pattern* Plasmid pattern Ribotype PFGE pattern Date of isolation
1 2 STR (R1) P6 I A Dec 2002
2 19 STR, SXT, NDA (R2) P1 I B Feb 2002
3 2 STR, SXT, NDA, TET (R3) P2 I A May 2003
4 2 STR, SXT, AMP, (R4) P3 I A Aug 2003
5 2 STR, SXT, NDA, TET (R3) P4 I A Sep 2003
6 14 STR, SXT, NDA, TET, AMX, C, AMP (R5) P5 II C Sep 2003
7 2 STR, SXT, AMP (R4) P6 I A Oct 2003
8 18 STR, SXT (R6) P7 I D Oct 2003
9 2 STR, SXT (R6) P6 I A Nov 2003
10 2 STR, SXT, AMP (R4) P6 I A Nov 2003
*AMP, ampicillin; AMX, amoxicillin-clavulanic acid; C, chloramphenicol; NDA, nalidixic acid; STR, streptomycin; TET, tetracycline; SXT, 
sulfamethoxazole-trimethoprim.BMC Research Notes 2008, 1:74 http://www.biomedcentral.com/1756-0500/1/2
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community settings and the phenotype instability
[24,25]. Indeed, all S. boydii strains were resistant to tri-
methoprim-sulfamethoxazole and all, but one, to strepto-
mycin, antibacterial drugs that are both commonly used
in Iran as an empiric therapy in the treatment of shigello-
sis and the other bacterial enteric diseases. Furthermore,
the changes in resistance phenotypes that have been
observed in Shigella have recently been supposedly attrib-
uted to the transposition activity of insertion sequences
distributed at high frequency through the genome with a
consequent disruption of antimicrobial resistance
sequences [25].
Plasmid profile analysis has been extensively used on
Shigella strains. This method is cheap and quick, requiring
one hour approximately of hands-on time, and 24 hours
to be completed. Shigella  species may harbor plasmids
ranging from 2 to as many as 10 different populations
[26,27]. Some previous studies used plasmid profiles to
characterize isolates of S. boydii [3,18,9]. The sizes of the
plasmids among all S. boydii isolates ranged from 1 to
21.2 kb that is comparable with the results previously
reported from USA [18] and Iran [9]. In our study, plas-
mid profile analysis was able to differentiate seven pat-
terns among 10 isolates: P6 only was shared by four
strains, while the remaining plasmid profiles were unique.
Litwin et al. [18] also found six plasmid patterns among
12 strains of S. boydii isolated from Pima County, Arizona
between April 1986 and May 1987. Those patterns con-
tained one to five plasmids which ranged in size from 1.4
to >20 kb. In other studies, however, plasmid profile anal-
ysis showed an identical plasmid pattern in 23 of 25
strains studied [3]. In a recent study carried out in Shiraz,
Iran, Farshad and her colleagues identified three geno-
types among three clinical isolates of S. boydii on the basis
of their plasmid profiles [9].
Plasmid profiles of S. boydii isolates Figure 1
Plasmid profiles of S. boydii isolates. P1–P7 are the represent-
ative plasmid profiles of the clinical samples. Lane M is molec-
ular size marker.
Ribotyping of S. boydii (PvuII digestion and Southern blotting) Figure 2
Ribotyping of S. boydii (PvuII digestion and Southern blotting). 
Lanes I and II are the representative ribotypes of the clinical 
strains. Citrobacter koseri DNA was digested by MluI and 
served as a molecular size marker (M).BMC Research Notes 2008, 1:74 http://www.biomedcentral.com/1756-0500/1/2
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Ribotyping was applied based upon previous findings
proving that rDNA restriction pattern analysis may be a
valuable tool in epidemiological research on S. boydii
[3,10]. In our study, however, all S. boydii strains were cat-
egorized into two patterns only. Moreover, all but one iso-
lates, belonged to ribotype I. Hence, in our setting
ribotyping did not prove to be useful, despite the encour-
aging results obtained on Shigella during previous investi-
gations [12,28]. However, our finding is similar to recent
reports from other developing countries, such as Bangla-
desh [29].
PFGE also, that has consistently proved to be a highly dis-
criminative subtyping method in epidemiological investi-
gation of many bacterial pathogens [30], divided our
strains into four groups closely associated to serotype. The
association of the serotype 2/PFGE A pattern subtype with
different plasmid profiles could suggest the circulation
during the period under study of a major endemic S. boydii
clone, including strains that were going through some dif-
ferentiation steps probably by acquisition or loss of extra-
chromosomal DNA.
Though our results have inherent limits due to the lowest
incidence of S. boydii infections in Iran and the conse-
quent small number of available strains, subtyping relying
upon more temporally and spatially stable molecular
markers, such as PFGE and ribotyping, suggests that
endemic circulation of this enteric pathogen should be
attributed to a few bacterial clones. Simultaneously, less
stable markers, such as drug resistance pattern and plas-
mid profile analysis, were very effective in finely discrimi-
nating apparently unrelated strains of S. boydii.
Conclusion
Low endemic circulation of S. boydii in Tehran, Iran, may
be attributed to a few clones diverging towards heteroge-
neous drug resistance phenotypes and plasmid profiles.
The different methods could provide more or less sensi-
tive interpreting keys suitable for long term – ribotyping,
PFGE – or short term – drug resistance and plasmid pat-
tern – epidemiological studies.
To our best knowledge, this is the first report on the char-
acterization by different methods of S. boydii strains iso-
lated in Iran. The results obtained from present study
could be helpful for a future epidemiological surveillance
of Shigella in this country.
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